#-#/# [013]

Related by string. #-#/# [009] * # [012] : #.# ov #-# / #/#- [002] : #/#-year-old son [002] * shed #-#/# pence [002] . #-#/# yr . shed #-#/# pence [001] . #-#/# pence valuing [002] . #-#/# lengths . WB #-#/# #-#/# . Proposition #-#/# . #-#/# #-#/# [005] . #-#/# yielding #.# [004] . #-#/#-year [002] . #-#/# yielding #.# [001] . #-#/# pence [001] . #-#/# pence [003] . #-#/# pence [002] *

Related by context. Frequent words. (Click for all words.) 64 #-#/# [004] 60 EURm 60 GAAP Adj 58 -Genereaux 56 Pro forma EBITDA 54 -Edgewater Networks 54 -Elmers 54 THE YEAR ENDED 54 OYJ 54 +#,# % [002] 53 MEUR 53 EBIT amounted 53 - + [014] 52 Change - [010] 52 Biol Psychiatry 52 + - + [001] 52 Supplementary Data 52 -irrelevancies 52 #.#.# #.#.# [006] 52 EBIT Margin 52 NET PROFIT 52 Non GAAP adjusted EBITDA 52 Foreign Currency Translation 52 +#,# % [001] 52 Computed 52 Ann Intern Med 52 Invested assets 52 RESULTS FOR 52 thethird quarter 51 OPERATING HIGHLIGHTS 51 OPERATING PROFIT 51 Annualized Return 51 retrospectively adjusted 51 Change - [003] 51 ANNUAL REPORT 51 Adjusted Non GAAP 51 FINANCIAL STATEMENTS 51 Adjusted EBIT 51 kEUR 51 -# -# [005] 51 CapMan Plc 51 Constant Currency 50 Segmental 50 -planting saplings 50 + - [007] 50 Pretax Income 50 EUR -#.# [003] 50 Consolidated adjusted EBITDA 50 + - + [002] 50 Normalized EBITDA 50 SHARE CAPITAL 50 # - -Huddinge 50 -Krefeld Germany 50 Arch Neurol 50 KEUR 50 THREE MONTHS ENDED DECEMBER 49 Noninterest Expense 49 [014] 49 -Luiza 49 J Clin Oncol 49 Interest Expenses 49 INCOME STATEMENT 49 + - + - [009] 49 -MediaSyndicate.com 49 [015] 49 STATEMENT OF CHANGES IN 49 MNOK 49 Annualised 49 -Rahael 49 GBP #.#m [003] 49 -#,# -#,# [009] 49 CONSOLIDATED INCOME STATEMENT 49 - + [007] 49 YTD YTD 49 Non GAAP Disclosures 49 TRY#.# [005] 49 RUB #.# [001] 49 Arch Intern Med 49 Consensus +#.# 49 -Tomine 48 OBLIGATIONS 48 FAS CAS pension 48 J Urol 48 Q#/# EUR [001] 48 EBITDAR margin 48 Portfolio Composition 48 QTD 48 -triseries 48 =shen 48 Guides FY# 48 MSEK 48 IN ACCORDANCE WITH 48 cmt 48 intersegment eliminations 48 Tangible Equity 48 Stock Compensation Expense 48 - -Staehely 48 3Q FY# 48 Certain comparative 48 RESULTS AND 48 # -GT2 RS

Back to home page